Literature DB >> 106721

Raised intracranial pressure: its management in Neisseria meningitidis meningoencephalitis.

S K Nugent, J A Bausher, E R Moxon, M C Rogers.   

Abstract

Further reduction in morbidity and mortality from bacterial meningitis is unlikely to stem from innovations in antibiotic management. Emphasis must therefore be directed toward prevention, more rapid diagnosis, and improved therapy for maintaining the integrity of the CNS. Raised intracranial pressure is frequently associated with bacterial meningitis. In selected patients with bacterial meningitis and clinical evidence of elevated intracranial pressure, monitoring and aggressive treatment of this pressure could be crucial to survival.

Entities:  

Mesh:

Year:  1979        PMID: 106721

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  6 in total

Review 1.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 2.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

3.  Cerebrospinal fluid pressure in pyogenic meningitis.

Authors:  R A Minns; H M Engleman; H Stirling
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

Review 4.  Brain edema and increased intracranial pressure in the pathophysiology of bacterial meningitis.

Authors:  U M Niemöller; M G Täuber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

5.  Variables affecting outcome from severe brain injury in children.

Authors:  Z Barzilay; A Augarten; M Sagy; E Shahar; Y Yahav; H Boichis
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

6.  Intracranial pressure in childhood central nervous system infections.

Authors:  P Rebaud; J C Berthier; E Hartemann; D Floret
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.